WePlay Launches "Let's Celebrate Christmas Together" Winter Campaign: Partnering with Korean Charity to Light Up the Journey Home for Stray Dogs

WePlay Launches "Let's Celebrate Christmas Together" Winter Campaign: Partnering with Korean Charity to Light Up the Journey Home for Stray Dogs

SEOUL, South Korea, Dec. 22, 2025 /PRNewswire/ -- WePlay, the global flagship social entertainment platform under WEJOY PTE. LTD., officially announced the launch of its "Let's Celebrate Christmas Together" campaign, running from December 19 to 25....

GAC Accelerates European Market Plan, Partnering with Magna to Deepen Localized Cooperation

GAC Accelerates European Market Plan, Partnering with Magna to Deepen Localized Cooperation

GRAZ, Austria, Nov. 21, 2025 /PRNewswire/ -- Today, GAC and Magna announced a widespread cooperation program to accelerate electric mobility and expand EV collaboration in Europe. The collaboration underscores GAC's regional commitment, extending...

Ximalaya Podcasts Elevate City Branding: Partnering with Ningbo to Launch a New Podcast Co-Creation Camp

Ximalaya Podcasts Elevate City Branding: Partnering with Ningbo to Launch a New Podcast Co-Creation Camp

NINGBO, China, June 25, 2025 /PRNewswire/ -- This year, audio platform Ximalaya has teamed up with the eastern Chinese port city of Ningbo to roll out "Reasons to Fall in Love with Ningbo–WAVE NINGBO," a joint podcast co-creation initiative. On June...

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

NEW YORK, June 24, 2025 /PRNewswire/ -- Klotho Neuroscience, Inc. (NASDAQ: KLTO), a US-based biogenetics company developing cell and gene- based treatments to address neurological conditions, including ALS, Alzheimer's Disease (AD) and Parkinson's...

menu
menu